Jae-Eun Joo

This inventor holds 4 USPTO granted patents and 3 published patent applications and 5 EPO patents. Top assignees: Yuhan Corporation, The Green Cross Corporation. Active years: 2019-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jae-Eun Joo. Retrieved from https://idiyas.com/inventor/jae-eun-joo-7jr5lcqx

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 (Patent Applications = 3)

% Patents Active = 100.0

EPO Patents = 5 (Patent Applications = 5)

Average Co-Inventor Count = 7.8

ph-index = 1

Company Filing History:

The Green Cross Corporation

patents

where one patent can have more than one assignee

Years Active: 2019-2026

Loading Chart...

4 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12673944 - Compounds having inhibitory activity against glucosylceramide synthase or pharmaceutically acceptable salt thereof, processes for preparing the same, and pharmaceutical compositions comprising the same (2026-07-07),

2. 12522602 - Derivatives having 2,3-dihydro-1H-indene or 2,3-dihydrobenzofuran moiety or pharmaceutically acceptable salt thereof and pharmaceutical compositions comprising the same (2026-01-13),

3. 12338237 - Derivatives having 1,2,3,4-tetrahydronaphthalene moiety or pharmaceutically acceptable salt thereof and pharmaceutical compositions comprising the same (2025-06-24),

4. 10383859 - Benzo[d]thiazole derivative or salt thereof, and pharmaceutical composition including same (2019-08-20),

Title: Jae-Eun Joo: Innovator in Pharmaceutical Chemistry

Introduction

Jae-Eun Joo is a prominent inventor based in Gyeonggi-do, South Korea. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target various diseases. With a total of 4 patents, her work is recognized for its potential impact on medical treatments.

Latest Patents

Jae-Eun Joo's latest patents include innovative compounds that have therapeutic applications. One of her notable inventions is a compound having a 1,2,3,4-tetrahydronaphthalene moiety or pharmaceutically acceptable salt thereof. This compound exhibits inhibitory activity against glucosylceramide synthase (GCS), making it useful for preventing or treating diseases such as Gaucher disease, Fabry disease, Tay-Sachs disease, and Parkinson's disease. Another significant patent is for a benzo[d]thiazole derivative or its pharmaceutically acceptable salt. This derivative selectively inhibits the protein-protein interaction between KRS and a laminin receptor, thereby inhibiting the migration of cancer cells. This invention holds promise for preventing or treating diseases associated with cancer cell metastasis.

Career Highlights

Throughout her career, Jae-Eun Joo has worked with reputable companies in the pharmaceutical industry. Notably, she has been associated with Yuhan Corporation and The Green Cross Corporation. Her experience in these organizations has contributed to her expertise in developing innovative pharmaceutical solutions.

Collaborations

Jae-Eun Joo has collaborated with several professionals in her field, including Eui-Chul Lee and Dong-Hoon Kim. These collaborations have likely enhanced her research and development efforts, leading to her successful patent applications.

Conclusion

Jae-Eun Joo is a distinguished inventor whose work in pharmaceutical chemistry has the potential to transform treatment options for various diseases. Her innovative patents reflect her commitment to advancing medical science and improving patient outcomes.

Profile summary based on public USPTO records.